Tools

LEADER 03949cam a2200637 i 4500

001 ocn793073726;

003 OCoLC;

005 20220513091706.0;

006 m o d f ;

007 cr c||||||||||;

008 120403s2011 dcua obt f000 0 eng ;

019 a| 1117847271;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0985-A-12 (online);

086 0 a| VA 1.107/3:AN 3;

100 1 a| Kansagara, Devan,e| author.=| ^A1033076;

245 10 a| Treatment of anemia in patients with heart disease :b| a systematic review /c| Devan Kansagara [and four others].;

264 1 a| Washington, DC :b| Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service,c| 2011.;

300 a| 1 online resource (iii, 78 pages) :b| illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "Evidence-based synthesis program.";

500 a| "October 2011.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references (pages 49-55).;

520 3 a| Anemia is very common in congestive heart failure (CHF) and coronary heart disease (CHD) patients. Anemia in CHF and CHD patients is associated with poorer outcomes, including an increased risk of hospitalization, decreased exercise capacity, and poor quality of life. Despite the association with poorer outcomes, it is unclear whether treating anemia or iron deficiency will improve outcomes. Anemia treatment strategies in heart failure and CHD patients include erythropoiesis-stimulating agents (ESAs) and red blood cell transfusions. Iron replacement in iron deficient patients with or without anemia has also been investigated. The objective of this evidence review is to evaluate the balance of benefit and harms of these treatments.;

536 a| Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center, Portland, OR, Devan Kansagara, M.D., M.C.R., Director.;

536 a| VA-ESPf| 05-225;

588 a| Description based on online resource; title from PDF cover (VA, viewed April 30, 2021).;

650 0 a| Anemiax| Treatmentz| United States.=| ^A12031;

650 0 a| Erythropoiesis.=| ^A2656;

650 0 a| Ironx| Physiological effectz| United States.=| ^A109727;

650 0 a| Bloodx| Transfusionz| United States.=| ^A437313;

650 0 a| Outcome assessment (Medical care)z| United States.=| ^A1006293;

650 7 a| Anemiax| Treatment.2| fast0| (OCoLC)fst00808624;

650 7 a| Bloodx| Transfusion.2| fast0| (OCoLC)fst00834613;

650 7 a| Erythropoiesis.2| fast0| (OCoLC)fst00915092;

650 7 a| Ironx| Physiological effect.2| fast0| (OCoLC)fst00979125;

650 7 a| Outcome assessment (Medical care)2| fast0| (OCoLC)fst01049109;

651 7 a| United States.2| fast0| (OCoLC)fst01204155?| UNAUTHORIZED;

655 7 a| Technical reports.2| lcgft;

710 2 a| Portland VA Medical Center.b| Evidence-based Synthesis Program Center.=| ^A1212022;

710 2 a| Evidence-based Synthesis Program (U.S.)?| UNAUTHORIZED;

856 40 u| https://purl.fdlp.gov/GPO/gpo1553137| 0;

922 a| UNREPORTEDPUBSSTAFF;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5635025;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5635025-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 6/10/2021x| EDOCUMENTz| JERESOURCE;

Treatment of anemia in patients with heart disease : a systematic review / Devan Kansagara [and four others].

Author/creator	Kansagara, Devan author.
Other author	United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
Other author	Portland VA Medical Center. Evidence-based Synthesis Program Center.
Other author	Evidence-based Synthesis Program (U.S.)
Format	Electronic
Publication	Washington, DC : Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, 2011.
Description	1 online resource (iii, 78 pages) : illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo155313
Subjects	Anemia--Treatment. --United States. Erythropoiesis. Iron--Physiological effect. --United States. Blood--Transfusion. --United States. Heart--Diseases. --Complications. --United States. Outcome assessment (Medical care)--United States.

Summary	Anemia is very common in congestive heart failure (CHF) and coronary heart disease (CHD) patients. Anemia in CHF and CHD patients is associated with poorer outcomes, including an increased risk of hospitalization, decreased exercise capacity, and poor quality of life. Despite the association with poorer outcomes, it is unclear whether treating anemia or iron deficiency will improve outcomes. Anemia treatment strategies in heart failure and CHD patients include erythropoiesis-stimulating agents (ESAs) and red blood cell transfusions. Iron replacement in iron deficient patients with or without anemia has also been investigated. The objective of this evidence review is to evaluate the balance of benefit and harms of these treatments.
General note	"Evidence-based synthesis program."
General note	"October 2011."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references (pages 49-55).
Funding information	Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center, Portland, OR, Devan Kansagara, M.D., M.C.R., Director.
Funding information	VA-ESP 05-225
Source of description	Description based on online resource; title from PDF cover (VA, viewed April 30, 2021).
Genre/form	Technical reports.
GPO item number	0985-A-12 (online)
Govt. docs number	VA 1.107/3:AN 3

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Treatment of anemia in patients with heart disease : a systematic review / Devan Kansagara [and four others].

Click here for more information about this title

Availability